This website uses cookies to store information on your computer. Some of these cookies are used for visitor analysis, others are essential to making our site function properly and improve the user experience. By using this site, you consent to the placement of these cookies. Click Accept to consent and dismiss this message or Deny to leave this website. Read our Privacy Statement for more.
Print Page   |   Contact Us   |   Sign In   |   Register
Community Search
CASSS Associate Directors
Share |

Our Leadership

Board of Directors

Associate Directors

Distinguished Fellows

Staff

 

 

 

 

Digital Strategy Report

 

    

Associate Directors (ADs) are “statutory members” of CASSS.  Membership in this committee is open to all who have participated as a volunteer on any of the CASSS meeting committees and who actively parcticipate in AD activities. In most professional societies you pay dues to join the organization.  In this way, CASSS is unique.  Our “dues” are participation instead of a monetary payment.  CASSS' ADs are a select group of members, made up of those who care enough about the organization to not just send in an annual check but actually contribute their time and expertise.  This is what gives us our strength. The ADs are also the members of CASSS charged with electing the Board and advising them on issues of importance to the membership-at-large. 

  • Siddharth Advant, Celgene Corporation
  • Wasfi Al-Azzam, TechnoPharmaSphere LLC
  • Justin Aldridge, Axovant Gene Therapies
  • Kris Antonsen, BioMarin Pharmaceutical Inc.
  • Thomas Arroll, Seattle Genetics, Inc.
  • Yves Aubin, Health Canada
  • Sandra Auguste-Bower, H. Lundbeck A/S
  • Evangelos Bakopanos, Health Canada
  • Jared Bee, REGENXBIO Inc.
  • Timothy Blanc, Eli Lilly and Company
  • Markus Blumel, Novartis Pharma AG
  • Michael Boyne, COUR Pharmaceuticals Development Company, Inc.
  • Michael Brenowitz, Albert Einstein College of Medicine
  • Holly Cargill, Pfizer, Inc.
  • David Carr, Bioanalytical Technologies
  • James Carroll, Pfizer, Inc.
  • Nina Cauchon, Amgen Inc.
  • Jen Chadwick, BioAnalytix, Inc.
  • Andrew Chang, Novo Nordisk Inc.
  • Michael Chang, PTC Therapeutics
  • Emmanuelle Charton, EDQM, Council of Europe
  • Guodong Chen, Bristol-Myers Squibb Company
  • Barry Cherney, Amgen Inc.
  • Judy Chou, Bayer
  • Natalie Ciaccio, Horizon Therapeutics
  • David Cirelli, Pfizer, Inc.
  • Steven Cohen, SAC Analytical Consultants
  • Mary Cromwell, Genentech, a Member of the Roche Group
  • Jill Crouse-Zeineddini, Amgen Inc.
  • Robert Cunico, Pacific Biolabs
  • Xiao-Ping Dai, IVERIC bio
  • Eef Dirksen, Synthon Biopharmaceuticals B.V.
  • Bharat Dixit, ClearB Therapeutics
  • John Dobbins, Eli Lilly and Company
  • Vladislav Dolnik, Alcor BioSeparations LLC
  • Narasaiah Dontha, Celgene Corporation, A Bristol-Myers Squibb Company
  • Roman Drews, Daiichi Sankyo, Inc.
  • Anders Dybdal Nielsen, LEO Pharma A/S
  • Julia Edwards, Genentech, a Member of the Roche Group
  • William Egan, GlaxoSmithKline
  • Christof Finkler, F. Hoffmann - La Roche AG
  • Frantisek Foret, Institute of Analytical Chemistry ASCR, v.v.i.
  • Kathleen Francissen, Genentech, a Member of the Roche Group
  • Michelle Frazier,
  • John Frenz, Northeastern University
  • Marta Germano, Janssen Infectious Diseases and Vaccines
  • Joseph Glajch, JLG AP Consulting LLC
  • Ralf Gleixner, Ares Trading SA, An affiliate of Merck Serono
  • Andras Guttman, University of Debrecen
  • Fadi Hakki, Viela Bio
  • Jason Hampson, Amgen Inc.
  • Mei Han, Amgen Inc.
  • Stephen Hartman, AbbVie Inc.
  • Julie Heflin, Abbvie Inc.
  • John Hennessey, Independent Consultant
  • Ping Hu, Janssen R&D, LLC
  • Chi-Ting Huang, Surface Oncology
  • Brendan Hughes, Bristol-Myers Squibb Company
  • Ronald Imhoff, MorphoSys AG
  • Guifeng Jiang, Jazz Pharmaceuticals, Inc.
  • Xu-Rong Jiang, AstraZeneca BioVentures
  • Carmilia Jimenez Ramirez, Ajinomoto Bio-Pharma Services
  • Peter Johnson, RETIRED
  • Franka Kalman, HES-SO Valais
  • Vinaya Kapoor, Tricida
  • Jon Kauffman, Eurofins Lancaster Laboratories, Inc.
  • Sarah Kennett, Genentech, a Member of the Roche Group
  • Maura Kibbey, United States Pharmacopeia Convention (USP)
  • Steffen Kiessig, F. Hoffmann-La Roche Ltd.
  • John Kim, Teva Pharmaceutical Products Ltd.
  • Kevin King, Pfizer, Inc.
  • Alistair Kippen, IPSEN Biopharm Ltd.
  • Yasuhiro Kishioka, Pharmaceuticals and Medical Devices Agency (PMDA)
  • Junichi Koga, Daiichi Sankyo Co., Ltd.
  • Isabelle Kohler, Leiden Academic Center for Drug Research
  • Carol Krantz, Seattle Genetics, Inc.
  • Robert Kuhn, Amgen Inc.
  • Joseph Kutza, AstraZeneca
  • Nathan Lacher, Pfizer, Inc.
  • Kathy Lee, Eli Lilly and Company
  • Ineui Lee, Kobe University
  • David Lee, bluebird bio, Inc.
  • Patricia Lewis, Omeros Corporation
  • Vivian Lindo, AstraZeneca
  • Aston Liu, GlaxoSmithKline
  • Anthony Lubiniecki, University of Maryland
  • Anders Lund, Synlogic, Inc.
  • Jiann-Kae Luo, Regeneron Pharmaceuticals, Inc.
  • Michelle Lytle, Eli Lilly and Company
  • Yelena Lyubarskaya, Sanofi
  • Mirek Macka, University of Tasmania
  • Helena Madden, bluebird bio, Inc.
  • Khalid Mahmood, Eli Lilly and Company
  • John Marino, National Institute of Standards and Technology (NIST)
  • Ingrid Markovic, Genentech, A Member of the Roche Group
  • Philip Marriott, Monash University
  • William Matousek, Regeneron Pharmaceuticals, Inc.
  • Robert Mattaliano, Genzyme, a Sanofi Company
  • Rob McCombie, Sangamo Therapeutics, Inc.
  • Bruce Meiklejohn, Omeros Corporation
  • David Michels, Genentech, a Member of the Roche Group
  • Ken Miller, AstraZeneca
  • Thomas Millward, Novartis Pharma AG
  • Edwin Moore, University of Illinois
  • Jamie Moore, Genentech, a Member of the Roche Group
  • Genesio Murano, BioScope Associates LLC
  • Wassim Nashabeh, F. Hoffmann - La Roche Ltd.
  • Jens Bjørn Nielsen, Novo Nordisk A/S
  • Shawn Novick, BioPhia Consulting, Inc.
  • Brian Nunnally, Seqirus, A CSL Company
  • Fionnuala O'Driscoll, Eli Lilly Kinsale Limited
  • Julia O'Neill, Direxa Consulting LLC
  • Bhavin Parekh, Eli Lilly and Company
  • Jun Park, Helixmith Co.
  • SungAe Park, Korea Biotechnology Industry Organization
  • David Passmore, Yumab GmbH
  • Mary Beth Pelletier, Biogen
  • Stefanie Pluschkell, Pfizer, Inc.
  • Christopher Pohl, Thermo Fisher Scientific
  • Francis Poulin, Sanofi
  • Lesley Redfern, AbbVie Inc
  • Gang (Gary) Ren, Lawrence Berkeley National Laboratory
  • Daisy Richardson, Merck & Co., Inc.
  • Anthony Ridgway, Health Canada
  • Noel Rieder, Amgen Inc.
  • Nadine Ritter, Global Biotech Experts, LLC
  • Richard Rogers, Juno Therapeutics, a Celgene Company
  • Sushmita Roy, BioMarin Pharmaceutical Inc.
  • Margaret Ruesch, Pfizer, Inc.
  • Reb Russell, Jazz Pharmaceuticals, Inc.
  • Richard Rustandi, Merck & Co., Inc.
  • Michael Sadick, Catalent Pharma Solutions
  • Oscar Salas, Sana Biotechnology
  • Cari Sänger van de Griend, Kantisto BV
  • Mark Schenerman, CMC Biotech-MAS Consulting
  • John Schiel, NIST - National Institute of Standards and Technology
  • Martin Schiestl, Sandoz GmbH
  • Timothy Schofield, CMC Sciences, LLC
  • Thomas Schreitmueller, F. Hoffman - La Roche Ltd.
  • Joanne Severs, Bayer
  • Zahra Shahrokh, ZDev Consulting and STC Biologics
  • Joseph Siemiatkoski, J. Siemiatkoski Consulting Inc.
  • Robert Sitrin, PATH
  • Lance Smallshaw, UCB Biopharma sprl.
  • Zoran Sosic, Biogen
  • Kannan Srinivasan, Thermo Fisher Scientific
  • Arne Staby, Novo Nordisk A/S
  • Jeff Staecker, BioPhia Consulting, Inc.
  • Robert Stevenson, American Laboratory/Labcompare
  • Annie Sturgess, Bristol-Myers Squibb Company
  • Shelley Suggett, Themistry, Inc.
  • Frantisek Svec, Lawrence Berkeley National Laboratory
  • Patrick Swann, Amgen Inc.
  • Jonathan Sweedler, University of Illinois at Urbana-Champaign
  • Garry Takle, Merck & Co., Inc.
  • Harold Taylor, Merz Pharma GmbH & Co. KGaA
  • Max Tejada, AstraZeneca
  • Hansjoerg Toll, Novartis
  • Kazuhisa Uchida, Kobe University
  • Paul Varley, Kymab Ltd
  • Kimberly May Vazquez, Immunomedics, Inc.
  • Hermann Wätzig, University of Braunschweig
  • Ziping Wei, BridgeBio LLC
  • Andrew Weiskopf, Sana Biotechnology
  • William Weiss, Eli Lilly and Company
  • Jolanda Westerlaken, UCB Pharma SA
  • Lance Wong, Strand Bio
  • Jason Wood, J Stuart Consulting
  • Jette Wypych, Amgen Inc.
  • Toyohiko Yamamoto, Asahi Kasei Pharma Corporation
  • Min Young, Ultragenyx Pharmaceutical Inc.
  • Christopher Yu, Genentech, a Member of the Roche Group
  • Heidi Zhang, Juno Therapeutics, A Celgene Company
  • Eike Zimmermann, Allogene Therapeutics
    

 

more Calendar

9/14/2020 » 9/17/2020
Mass Spec 2020

9/28/2020 » 10/1/2020
CE Pharm 2020

Membership Software Powered by YourMembership  ::  Legal